BRCTF
Price:
$31.78
Market Cap:
$27.48B
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company's therapeutic areas encompass neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and other CNS diseases. In addition, it owns a technology platform, which develops a range of therapeutic monoclonal antibodies. Additionally, the company is developing lecanemab, which is in phase 3 clinical trials; Lecanemab that is in back-up phase 3 clinical trials; Exidavnemab, which is in phase 2 clinical trials; Lecanemab, BAN280...[Read more]
Industry
Biotechnology
IPO Date
2022-11-29
Stock Exchange
OTC
Ticker
BRCTF
According to BioArctic AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 127.12. This represents a change of -165.30% compared to the average of -194.68 of the last 4 quarters.
The mean historical PE Ratio of BioArctic AB (publ) over the last ten years is -198.66. The current 127.12 PE Ratio has changed -6498.78% with respect to the historical average. Over the past ten years (40 quarters), BRCTF's PE Ratio was at its highest in in the March 2017 quarter at 570.87. The PE Ratio was at its lowest in in the September 2017 quarter at -5576.92.
Average
-198.66
Median
23.56
Minimum
-2092.31
Maximum
125.75
Discovering the peaks and valleys of BioArctic AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.29%
Maximum Annual PE Ratio = 125.75
Minimum Annual Increase = -228.88%
Minimum Annual PE Ratio = -2092.31
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 26.91 | -126.98% |
| 2024 | -99.75 | -196.84% |
| 2023 | 103.00 | -104.92% |
| 2022 | -2092.31 | 2.29% |
| 2021 | -87.65 | -28.34% |
| 2020 | -122.31 | -228.88% |
| 2019 | 94.90 | 369.62% |
| 2018 | 20.21 | -83.93% |
| 2017 | 125.75 | 181.85% |
| 2016 | 44.62 | -93.52% |
The current PE Ratio of BioArctic AB (publ) (BRCTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.05
5-year avg
-429.96
10-year avg
-198.66
BioArctic AB (publ)’s PE Ratio is greater than HBM Holdings Limited (23.10), greater than Neuren Pharmaceuticals Limited (90.17), greater than Dermapharm Holding SE (15.30), greater than Hisamitsu Pharmaceutical Co., Inc. (22.44), greater than Mesoblast Limited (-20.44), greater than Oxford Nanopore Technologies plc (-7.93), greater than Pharma Mar, S.A. (23.61), greater than Fagron N.V. (17.96), greater than Tsumura & Co. (9.86), greater than Genus plc (31.39),
| Company | PE Ratio | Market cap |
|---|---|---|
| 23.10 | $1.30B | |
| 90.17 | $1.71B | |
| 15.30 | $2.36B | |
| 22.44 | $2.04B | |
| -20.44 | $2.20B | |
| -7.93 | $1.48B | |
| 23.61 | $1.52B | |
| 17.96 | $2.02B | |
| 9.86 | $1.73B | |
| 31.39 | $2.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioArctic AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioArctic AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BioArctic AB (publ)'s PE Ratio?
How is the PE Ratio calculated for BioArctic AB (publ) (BRCTF)?
What is the highest PE Ratio for BioArctic AB (publ) (BRCTF)?
What is the 3-year average PE Ratio for BioArctic AB (publ) (BRCTF)?
What is the 5-year average PE Ratio for BioArctic AB (publ) (BRCTF)?
How does the current PE Ratio for BioArctic AB (publ) (BRCTF) compare to its historical average?